Table 1

Overview of the assessments

Activity/assessmentT-1T0T1T2T3
PrestudyBaseline (week 0)4 weeks after T012 weeks after T06 months after T0
Eligibility screenX
Informed consentX
Primary outcome
Insomnia severity (ISI)XXXX*
Secondary outcomes
Sleep quality (PSQI)XXXX
Quality of life (AQoL-8D)XXXX
Depressive symptoms (QIDS-SR16)XXXX
Anxiety symptoms (GAD-7)XXXX
Somatic symptoms (SSS-8)XXXX
Costs (TiC-P)XXX
Potential treatment moderators and mediators
DBAS-10XXXX
Pre-sleep arousal (PSAS)XXXX
Fatigue (BFI)XXXX
Stress (PSS)XXXX
Sleep hygiene behaviour (SHI)XXXX
Emotion regulation (CERQ-short)XXXX
Intervention-related variables
Alliance (WAI-I)X†
Technological alliance (TAI-OT)X†
Client satisfaction (CSQ-8)X
Adverse events and negative effects (NEQ, Questionnaire on adverse effects of CBT-I)XX
Dropout QuestionnaireX‡
  • *The ISI at T3 (6 months after T0) is the primary outcome of this trial.

  • †Only in patients of the intervention groups (IG1, IG2, IG3) who entered step 2 of the stepped care model.

  • ‡Only in patients of the intervention groups (IG1, IG2, IG3) not completing at least 80% of the internet-delivered intervention.

  • AQoL-8D, Assessment of Quality of Life instrument; BFI, Brief Fatigue Inventory; CERQ-short, Cognitive Emotion Regulation Questionnaire; CSQ-8, Client Satisfaction Questionnaire; DBAS-10, Dysfunctional Beliefs and Attitudes about Sleep Scale; GAD-7, General Anxiety Disorder 7 questionnaire; ISI, Insomnia Severity Index; NEQ, Negative Effects Questionnaire; PSAS, Pre-Sleep Arousal Scale; PSQI, Pittsburgh Sleep Quality Index; PSS, Perceived Stress Scale; QIDS-SR16, 16-item Quick Inventory of Depressive Symptoms in the self-report format; SHI, Sleep Hygiene Index; SSS-8, Somatic Symptom Scale 8; TAI-OT, Technological Alliance Inventory; TiC-P, Trimbos/iMTA questionnaire for costs associated with psychiatric illness; WAI-I, Working Alliance Inventory for guided Internet interventions.